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and only 5 (4.8%) scored in the highly medically accurate range (116-132). Individual
item score range was 2.47-3.35. Thirteen items (39%) scored in the mixed medically
accurate-inaccurate range and included items in all 4 HF REP attributes. Greatest inac-
curacy was related to understanding the silent processes of HF (hormones and sodium
influence), illness curability and HF persistence over time, even when asymptomatic. Pre-
dictors of highly medically accurate HF-REP were young age, education, widowed,
asthma history, research trial participation, transplant evaluation, HF specialty physician,
outpatient status and healthcare visit not due to HF exacerbation; all P < 0.03. Conclu-
sion: Patients have medically inaccurate HF-REP, necessitating education and counsel-
ing. Written self-care education materials should focus on HF-REP content that provides
an accurate mental image of HF as a threat that requires ongoing self-care maintenance
and not just on content explaining how to carry out HF behaviors.
1153-69 Investigation of a Unique Approach to Patient 
Interactive Education: The Audience Response Method
James S. Rosneck, David Newman, Donna Waechter, Isadore Newman, Richard 
Josephson, Summa Health System, Akron, OH, The University of Akron, Akron, OH
Background: Traditional live lecture format (LL) has been the hallmark of risk education.
This method of adult education has been questioned. Cognitive learning goals may be
better accomplished when adults are actively involved in the process. We evaluated the
effectiveness of an interactive patient education program (AR) using the Audience
Response System™.
Methods: 158 Subjects were randomly assigned to either LL or AR education sessions
for three teaching units Cholesterol, Blood Pressure and Exercise. Patients in the AR
were asked multiple choice questions projected on a screen as part of a live presenta-
tion. The patient’s answers were registered in a computer via remote control hand held
transmitters. Correct responses and the patient’s (anonymous) group aggregate
responses were projected for review and comment by the instructor and respondents. LL
sessions were conducted by the same instructor following a plan with identical goals.
After LL & AR sessions a posttest measuring teaching goals was completed by both
groups.
Results:The AR group scored significantly higher on post testing than LL cohorts across
all teaching units and when controlling for differences in race, gender and age. 
Conclusions: An innovative approach to patient education increased achievement of
short-term learning goals when patients interacted in a learning situation. Knowledge
acquisition of health care information was improved. Patient education may be enhanced
through the use of modern innovative teaching technology. 
1153-70 Reasons for Nonadherence to Cardiac Medications in 
Patients Discharged With Acute Coronary Syndromes
Anchal Sud, Eva M. Kline-Rogers, Jianming Fang, Steve R. Erickson, David Armstrong, 
Krishna Rangarajan, Richard Otten, Kim A. Eagle, University of Michigan, Ann Arbor, MI
Background: Optimal use of evidence based medicines(meds) in acute coronary syn-
drome(ACS) patients significantly decreases morbidity and mortality, yet, many pts are
not adherent to administered meds. We determined the rates and reasons for non-adher-
ence to beta-blockers (BB), ACE inhibitors (ACE), lipid lowering agents (LLA), and aspirin
(ASA) in ACS pts 6 months post discharge.
Methods: We administered a standardized telephone survey to a cohort of ACS patients
six months post discharge. The survey included a standardized adherence questionnaire
(Morisky Adherence Scale), demographic data, current meds, meds at discharge, and
reasons for discontinuing meds.
Results: A total of 154 patients were interviewed at a median of 8.3 months after dis-
charge; mean age of 64.3 (±12.7), 54.4% male, 96% Caucasian, 55.6% having some col-
lege education, and 88.4% living with at least one other person. Discharge rates for meds
were: BB 91.2%, ACE 71.0%, LLA 80.33%, ASA 91.4%. Of those discharged with the
medication, 87.7% continued to use BB at follow-up, 89.8% ACE, 88.8% LLA, and 91.5%
ASA. The primary reason for nonadherence was “my physician did not think it was nec-
essary (54.0%)", followed by other reasons including, “I did not like the side effects of the
medicine”(9.2%) and “I cannot afford the medication”(5.3%). For patients reportedly tak-
ing the cardiac meds, 50.4% indicated some level of nonadherence. Specifically, 41.5%
reported some nonadherence with B.B., 40.8% with ACE, 48.6% with LLA, and 43.1%
with ASA. The main reason was forgetfulness, followed by carelessness.
Conclusion: Our study reported higher adherence than that in the literature, possibly
reflecting our cohort (younger and with more education than usual) and/or a targeted
quality program in ACS pts at our institution (ACC GAP Program). In our experience,
inability to pay is not a common reason for nonadherence. Physicians must understand
the reasons behind noncompliance in order to improve adherence and significantly
impact patient health status.
1153-71 How Many Heart Failure Patients Are Compliant With 
Their Therapeutic Regimen?
Martje H. van der Wal, Tiny Jaarsma, Ivonne Lesman-Leegte, Marie Louise Luttik, 
Jochem Hogenhuis, Dirk Jan van Veldhuisen, University Hospital Groningen, Groningen, 
The Netherlands
Introduction: Patients with heart failure (HF) have a complex therapeutic regimen consist-
ing of medication, sodium and fluid restriction, daily weighing and recommendations on
activity and rest. Although knowledge alone is not sufficient to achieve compliance, it is
one of the prerequisites.
The aim of this study was to describe the compliance of patients with HF and examine
the relationship between knowledge and compliance.
Method: A sample of 205 hospitalized HF patients (mean age 70 years ±11; 39% female;
mean LVEF 32%, ± 12) from 14 Dutch hospitals was included in this study. During hospi-
talization basic characteristics were assessed and patients completed the following
Questionnaires: Dutch HF Knowledge scale, HF Self-care Behavior Scale, HF Belief
Scale and the HF Compliance Questionnaire.
Results: Nineteen percent of the patients did not reach the target of 80% compliance.
This included compliance with appointments at the outpatient clinic, medication, diet and
fluid restriction.
Mean compliance score on medication was 96%; compliance with appointment keeping
92%; compliance with diet 80%. Eighteen percent of the patients weighed daily; 52%
weighed less than once a week.
Mean knowledge score on a 15-item scale (min.0; max. 15) was 9.7 (± 2.6). Overall com-
pliance was significantly related to HF knowledge (r=.22, p<.01), experienced benefits of
medication and diet (r=.21, p<.01) and HF self-care behavior (r=.20,p<.01). Overall com-
pliance and HF knowledge was not related to age and gender.
Conclusion: Almost 1 out of 5 patients with heart failure does not reach 80% compliance
with the HF regimen. Self-reported overall compliance to medication in HF patients is
high, but compliance to diet and daily weighing is low. Compliance of patients with HF is
related to their HF knowledge and self care behavior.
1153-72 Depression in Smokers Hospitalized With Acute 
Cardiovascular Disease Increases Nicotine Withdrawal 
Symptoms and Early Relapse to Smoking
Anne Thorndike, Nancy Rigotti, Susan Regan, Kathleen McKool, Susan Swartz, Daniel 
Singer, Richard Pasternak, Massachusetts General Hospital, Boston, MA, Maine Medical 
Center, Portland, ME
Background: Hospitalization for cardiovascular disease (CVD) represents a unique
opportunity to initiate smoking cessation. Depression occurs frequently in CVD patients.
In outpatient settings, depressed smokers are less likely to quit smoking than non-
depressed smokers.
Methods: To determine the impact of depression on nicotine withdrawal symptoms dur-
ing hospitalization and early relapse to smoking after discharge, we analyzed data on
260 smokers hospitalized with a CVD diagnosis (unstable angina, myocardial infarction,
and peripheral vascular disease) who were enrolled in a randomized controlled trial of
bupropion vs. placebo for smoking cessation. All subjects received intensive smoking
counseling in the hospital and by telephone after discharge. Depressive symptoms were
measured by the Beck Depression Inventory (BDI), and smoking status was assessed by
patient self-report at 48 hours, 1 week, and 2 weeks after hospital discharge. We used
multiple logistic regression to determine the influence of baseline depressive symptoms
on withdrawal symptoms during hospitalization and relapse to smoking at follow up.
Results: At baseline, 54 (20%) smokers were depressed (defined by a BDI score > 16).
Depressed smokers were less likely than non-depressed smokers to have remained
abstinent from smoking at 48 hours (52% vs. 66%, p=.06), 1 week (37% vs. 60%,
p<.001), and 2 weeks (22% vs. 53%, p< .001) after discharge. Women (p=.005) and non-
whites (p=.002) were more likely to be depressed. Depressed smokers had more with-
drawal symptoms (p=.003) and cravings (p=.03) during hospitalization than the non-
depressed smokers, even when controlling for daily cigarette consumption and nicotine
dependence. Depressed and non-depressed smokers did not differ significantly in the
number of cardiac events that occurred during the first 2 weeks after discharge.
Conclusions: Depression is a significant risk factor for early relapse to smoking among
patients hospitalized with acute CVD, and depressed smokers suffer from more with-
drawal symptoms during hospitalization. By early recognition of the link among with-
drawal symptoms, depression, and early smoking cessation, CVD outcomes can likely be
improved.
1153-73 Moderate Alcohol Use Is Associated With Reduced 
Cardiovascular Risk in Patients Following Complicated 
Acute Myocardial Infarction
Trygve Brügger-Andersen, Volker Pönitz, Steven M. Snapinn, Kenneth Dickstein, Central 
Hospital in Rogaland, Stavanger, Norway
Background: 62% of adult Americans self-reported alcohol consumption during the year
2000. The impact on prognosis in patients with coronary artery disease is uncertain. Pre-
vious studies suggest a J-shaped relationship between alcohol use and survival following
myocardial infarction (MI) with an increased cardiovascular mortality (CV-mortality) asso-
ciated both with abstinence and excessive use. We related alcohol use to all-cause mor-
tality and adjudicated CV-mortality in patients following complicated MI.
Methods: In the OPTIMAAL trial, 5,477 patients from 7 Western European countries with
heart failure and/or evidence of left ventricular dysfunction following MI were recruited.
Alcohol use at baseline was assessed and related to clinical outcomes. Patients were
stratified by the frequency of the use of alcohol into either non-users (n=2,160), moderate
users (1-7 drinks/week, n=2,753) and heavy users (>7 drinks/week, n=545).
Results: 946 deaths were reported in the trial. Adjusted for age and smoking status,
Topic
Live Lecture Audience Response t – Test Analysis of
Covariance
Mean N SD Mean N SD
Cholesterol 78% 43 15% 86% 51 11% .005 .022
Blood Pressure 85% 56 15% 96% 56 8% .0009 .0009
Exercise 86% 49 15% 93% 48 11% .010 .006








patients with moderate use of alcohol had 23.8% lower risk of all-cause death (p<.00016)
and a 25.8% lower risk of CV-death (p<.00017) than non-users. There was no significant
difference between non-drinkers and heavy-drinkers with regard to survival following
adjustment for age and smoking status.
Conclusion: Our results demonstrate a positive and strong association between 
moderate alcohol use and survival in a cohort of patients following complicated MI.
1153-74 Physician Counseling Can Influence Health-Related 
Quality of Life
Barbara L. Lytle, Gregory J. Shook, Karen P. Alexander, Patricia A. Cowper, Daniel B. 
Mark, Elizabeth R. DeLong, Duke Clinical Research Institute, Durham, NC
Background: Secondary prevention counseling (SPC) by physicians (MDs) is a vital
component of guidelines-based care after hospitalization for coronary artery disease
(CAD). Yet, there is limited evidence of its benefits on patient (pt) well-being. Among
1298 members of two not-for-profit managed care organizations, we evaluated the rela-
tionship between reported SPC and self-rated health improvement following a CAD hos-
pitalization. Methods: All pts were surveyed approximately 9 months after a
hospitalization for unstable angina, myocardial infarction, percutaneous intervention, or
coronary artery bypass surgery. Health-status was assessed using the SF-36 Reported
Health Transition scale. Results: One quarter (28%) of all pts reported feeling “much bet-
ter” compared to the previous year. Compared to others, pts were more likely to feel
much better if they reported SPC about management of chest pain (29% vs 23%), cho-
lesterol (30% vs 20%), blood pressure (29% vs 22%), and diabetes (30% vs 25%), as
well as exercise advice (30% vs 18%), heart attack symptoms (29% vs 25%), and when
to go to the emergency room (29% vs 25%). A dramatic gradient in well-being was
observed according to respondent ratings of whether the MD was easy to understand:
strongly agree (35% much better), agree (20%), not sure (13%), disagree (8%), strongly
disagree (11%). In stepwise logistic regression, after controlling for the reason for hospi-
talization, significant predictors of feeling much better were understandable MD language
(p<0.0001), review of symptoms of a heart attack (p=.003), and advice on cholesterol
control (p=.03) and exercise (p=.03). Conclusion: Comprehensive SPC in understand-
able language has a demonstrable effect on a patient’s sense of well-being. As a compo-
nent of quality healthcare, the importance of these interactions on the overall health of
pts should not be underestimated.
1153-75 Physician Beliefs About the Treatment of 
Hyperlipidemia and Treatment to National Cholesterol 
Education Program Low-Density-Lipoprotein 
Cholesterol Goal in High-Risk Patients
Kathleen A. Foley, Ross J. Simpson, Jr., Kathy Berra, Shiva Sajjan, Leona E. Markson, 
Charles M. Alexander, Merck & Co., Inc., West Point, PA
Background: Many high-risk patients do not receive therapy that is sufficiently aggressive
to achieve LDL-C goal. This study describes the relationships between physician beliefs
and statin treatment decisions for high-risk patients.
Methods: A cross-sectional study of 108 physicians and 1,187 statin-treated patients with
a NCEP LDL-C goal <l00 mg/dL was conducted in 2002. Physicians completed a survey
prior to enrolling patients. Treatment history was collected from a chart review. Beliefs
were measured using validated scales with a 5-point scale. Patient follow-up was catego-
rized into changes that increased or decreased a patient’s chance of goal attainment.
The relationships between physician beliefs and type of follow-up change were analyzed
using multivariate GEE models to account for physician effect, controlling for patient char-
acteristics. Odds ratios (95% CI) are reported.
Results: The majority of physicians were in internal medicine (51%) or general practice
(38%). Mean patient age was 65.8 (SD 10.6) and 56% were male. Mean pre-treatment
LDL was 154.5 (SD 43.8). On average, physicians treated these patients for 3.5 years.
Although 75% of physicians agree with guidelines that close enough to goal is not good
enough, 43% of these high-risk patients were not at LDL-C goal and 35% who were not
at goal with initial therapy were either down-titrated, had no change in therapy or had an
ambiguous change. Mean follow-up LDL was 122.8 (SD 24.2) for those not at goal. 70%
of physicians did not believe treating to goal was an urgent need. Physician beliefs asso-
ciated with a decreased chance of goal attainment at follow-up included risks associated
with titrating a statin (OR:1.70; 1.13 – 2.56), getting patients within 10 or 20 points of goal
is close enough (OR: 1.83; 1.24 – 2.69) and current statin therapies are not effective for
getting patients to goal (OR: 4.76; 3.03 – 7.46).
Conclusions: While most physicians agree with current treatment guidelines, their beliefs
about statins and the urgency of treating hyperlipidemia may act as barriers to treating
patients to goal. Programs such as NCEP should incorporate information on physician
beliefs to further improve patient outcomes in clinical practice.
1153-76 Engaging Personal Physicians as Study Investigators: 
Can It Enhance Patient Enrollment in Clinical Trials?
Noelle Sherber, Neil R. Powe, Joel B. Braunstein, Johns Hopkins Medical Institutions, 
Baltimore, MD
Background: Limited enrollment in clinical trials obscures significant findings, wastes
resources, and unnecessarily exposes participating patients to harm. Evaluating ways to
improve enrollment, we asked whether patients would be more willing to participate
(WTP) in a cardiovascular drug trial if their personal rather than an unfamiliar physician
was engaged as the study investigator.
Methods: We approached 1440 randomly selected patients from 13 Maryland-based
outpatient cardiology and general medicine clinics to complete an 80-item self-adminis-
tered questionnaire. Respondents read a 1-page trial description and reported their WTP
using a 5-point Likert response scale. We then asked respondents their WTP if their per-
sonal rather than an unfamiliar physician was the study investigator. Patients rated trust
in physicians and quality of their health care experiences, to assess the importance of
these factors to explain any differences in WTP between personal and unfamiliar physi-
cian.
Results: Of 1132 patients eligible, 789 (70%) patients responded. Including only those
with a personal physician and complete data (n=666), patients were mean (sd) aged 55
(15) years, 53% female, and 33% black. Patients were “very likely/likely” to participate in
the study 56% of the time if conducted by their personal compared to only 36% if by an
unfamiliar physician (p<0.0001). After adjusting for age, race, gender, and socioeconomic
and health status, only presence of a family member or friend in health care was posi-
tively associated with “very likely/likely” WTP with unfamiliar physician (OR, 95% CI =
1.42, 0.99-2.03). If by a personal physician, however, trust in physician (1.57, 1.16-2.11,
per 1/5 unit increase), rating of health care quality (1.18, 1.06-1.31, per 1/10 unit
increase), and having a family member or friend in health care (1.57, 1.16-2.11) were
important predictors of WTP.
Conclusion: Patients are much more likely to enroll in a clinical trial if their personal phy-
sician is engaged as a study investigator. Greater enrollment through use of personal
physicians could relate to the importance of communication, trust, and familiarity with the
health system in patients’ participation decisions.
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846-1 Volume-Based Referral for Coronary Artery Bypass 
Graft Surgery and Percutaneous Coronary Intervention: 
Is the Volume Juice Worth the Squeeze?
Andrew J. Epstein, Saif S. Rathore, Harlan M. Krumholz, Kevin G.M. Volpp, University of 
Pennsylvania Wharton School of Business, Philadelphia, PA, Yale University School of 
Medicine, New Haven, CT
Background: Hospital volume minimums for coronary bypass graft (CABG) and percuta-
neous coronary intervention (PCI) have been advocated to reduce mortality. The number
of patients affected and lives saved by adopting volume minimums is unknown.
Methods: Using data from the 1998-2001 Nationwide Inpatient Sample, an administra-
tive database of discharges from a sample of US hospitals, we classified hospitals as low
volume hospitals (LVHs) if they did not meet annual procedure volume minimums recom-
mended by the Leapfrog Group (CABG 450 cases, PCI 400 cases); all other hospitals
were considered high volume (HVH). Multivariable logistic regression analyses were
used to evaluate the independent association between hospital volume and in-hospital
mortality adjusting for patient factors. Lives saved by the adoption of hospital volume min-
imums were estimated by predicting mortality assuming all LVH patients were instead
treated at HVHs.
Results: Patients at LVHs had a higher crude in-hospital mortality rate for CABG (3.85%
vs. 3.51% HVH, P=0.015) and PCI (1.96% vs. 1.43%, P<0.001). Odds of in-hospital mor-
tality remained higher for patients treated at LVHs for CABG (OR 1.16, 95% CI 1.09-1.23)
and PCI (OR 1.12, 95% CI 1.05-1.20) after multivariable adjustment. Treating all US
patients at HVHs would require moving 143,687 CABG cases and 87,661 PCI cases
from LVHs each year. Based on the association of volume and mortality and assuming
that the mortality risk for transferred patients would be comparable to that of patients cur-
rently treated at HVHs, moving LVH cases to HVHs would save an estimated 625 lives
annually among CABG patients and 109 lives annually among PCI patients. Averting a
single volume-associated death for CABG patients would require treating 230 patients at
HVHs instead of LVHs, while 805 PCI patients would have to be treated at HVHs instead
of LVHs to avert one volume-associated death annually.
Conclusion: Applying hospital volume-based minimums for CABG and PCI in the US
would require moving 231,348 cases annually from LVHs to HVHs and, in the most opti-
mistic case, result in 1,035 fewer deaths. The feasibility and costs of such a volume-
based referral policy are unknown.
Alcohol use at baseline and survival compared to non-users (HR=hazard ratio)
Alcohol use (drinks/week) 1-7 >7
All-cause mortality, unadjusted
(n=946)
HR 0.58 (0.51-0.66; 
p<.00001)
HR 0.63 (0.50-0.80; 
p<.00015)
All-cause mortality, adjusted for 
age and smoking status
HR 0.76 (0.66-0.88; 
p<.00016)
HR 1.01 (0.79-1.29; p<.93)
CV-mortality, unadjusted
(n=783)
HR 0.56 (0.48-0.65; 
p<.00001)
HR 0.60 (0.46-0.78; 
p<.00015)
CV-mortality, adjusted for age 
and smoking status
HR 0.74 (0.64-0.87; 
p<.00017)
HR 0.97 (0.74-1.28; p<.85)
